Concourse Financial Group Securities, Inc. Aslan Pharmaceuticals LTD Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ASLN
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About ASLAN Pharmaceuticals Ltd
- Ticker ASLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,744,704
- Market Cap $41.8M
- Description
- ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...